study found TTFields significantly reducing the abnormal glycolysis in human GBM (a type of brain cancer), by lowering the expression of the biomarker pyruvate kinase M2 (PKM2), and this reduction can be non-invasively detected using a novel radiotracer, [18F]DASA-23 (20). This evidence concerns the gene PKM and glioblastoma.